Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age

Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age

Bibliographic Details
Main Authors:	Morais-Almeida, Mário, Arêde, Cristina, Sampaio, Graça, Borrego, Luis Miguel
Format:	Online
Language:	English
Published:	Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731479/

Similar Items

Safety and Efficacy of Tree Pollen Specific Immunotherapy on the Ultrarush Administration Schedule Method Using Purethal Trees
by: Bozek, Andrzej, et al.
Published: (2014)

Twelve-Hour Ultrarush Immunotherapy in a Patient With Mastocytosis and Hymenoptera Sting Anaphylaxis
by: Jäger, Doris, et al.
Published: (2009)

Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections
by: Kim, Laura, et al.
Published: (2014)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
by: Yalcin, Arzu Didem, et al.
Published: (2013)

Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
by: Kim, Myoung-Eun, et al.
Published: (2011)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
by: Rondon, Carmen, et al.
Published: (2015)

Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance
by: Köhli-Wiesner, Alice, et al.
Published: (2012)

Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol
by: Patella, Vincenzo, et al.
Published: (2012)

Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
by: Nahm, Dong-Ho, et al.
Published: (2012)

Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement
by: Taher, Yousef A., et al.
Published: (2010)

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
by: Nahm, Dong-Ho, et al.
Published: (2016)

Anaphylaxis during specific subcutaneous immunotherapy against ragweed allergen -- case record
by: Prnjavorac, Besim, et al.
Published: (2014)

207 Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis
by: Fiocchi, Alessandro, et al.
Published: (2012)

13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation
by: Distler, Andreas, et al.
Published: (2015)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
by: Da Fonseca, Mario Henrique Almeida, et al.
Published: (2015)

Allergen immunotherapy
by: Crisafulli, Giuseppe, et al.
Published: (2014)

Immunotherapy – 2074. Tolerability of sublingual immunotherapy with tropical mite allergen vaccines using different dosing schedules in asthmatic children
by: Almarales, Raúl Lázaro Castro, et al.
Published: (2013)

Safety and efficacy of a sublingual-oral desensitization protocol in cow’s milk allergy treatment
by: Piedade, S, et al.
Published: (2013)

Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
by: Akdis, Cezmi A, et al.
Published: (2015)

Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy
by: Jacobsen, Lars, et al.
Published: (2012)

Allergen-specific immunotherapy
by: Moote, William, et al.
Published: (2011)

Mechanisms of allergen-specific immunotherapy
by: Fujita, Hiroyuki, et al.
Published: (2012)

Characteristics of candidates for allergen immunotherapy
by: Ciprandi, Giorgio, et al.
Published: (2013)

Allergen-Specific Immunotherapy in Asthma
by: Jutel, Marek
Published: (2014)

Allergen-specific immunotherapy
by: William Moote, et al.
Published: (2018-09-01)

Allergen immunotherapy in pregnancy
by: Oykhman, Paul, et al.
Published: (2015)

New treatments for allergen immunotherapy
by: Akdis, Mübeccel
Published: (2014)

Aluminium in Allergies and Allergen immunotherapy
by: Jensen-Jarolim, Erika
Published: (2015)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
by: Marth, Katharina, et al.
Published: (2014)

Allergen-Specific Immunotherapy in Food Anaphylaxis
by: Kerzl, Regina, et al.
Published: (2008)

Allergen Immunotherapy: A Centenary Celebration
by: Durham, Stephen R, et al.
Published: (2011)

Allergen immunotherapy in asthma; what is new?
by: Passalacqua, Giovanni, et al.
Published: (2015)

Monitoring Allergen Immunotherapy Effects by Microarray
by: Lupinek, Christian, et al.
Published: (2016)

Allergen Immunotherapy: Past, Present, and Future
by: Jutel, Marek, et al.
Published: (2016)

Is The Allergen Really Needed in Allergy Immunotherapy?
by: Kündig, Thomas M., et al.
Published: (2014)

Immunotherapy – 2073. Therapeutic effect of mite allergen vaccines by subcutaneous route in allergic Cuban asthmatic patients
by: Almarales, Raúl Lázaro Castro, et al.
Published: (2013)

Cluster Subcutaneous Allergen Specific Immunotherapy for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis
by: Feng, Shaoyan, et al.
Published: (2014)

Impact of subcutaneous specific-allergen immunotherapy in the quality of life of brazilian moderate/severe atopic dermatitis patients
by: Teixeira, Ana Julia, et al.
Published: (2015)

Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients
by: Pfaar, Oliver, et al.
Published: (2015)

Epidemiological survey on the practice of allergen immunotherapy in Brazil
by: De Magalhães Rios, José Luiz, et al.
Published: (2015)